Blood test may cut asthma attacks in half

NCT ID NCT07486401

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether using a blood test that measures eosinophil levels can help doctors tailor asthma treatments more effectively than standard care. About 240 adults with mild to moderate asthma will be followed for one year. The goal is to see if this approach reduces asthma attacks, improves symptom control, and enhances quality of life.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASTHMA EXACERBATIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

asthma status asthmaticus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • National Healthcare Group Polyclinics

    RECRUITING

    Singapore, 308205, Singapore

    Contact Phone: •••-•••-•••• Email: •••••@•••••